Suppr超能文献

静脉注射维拉帕米对心律失常的即时效应。

Immediate effects of intravenous verapamil in cardiac arrhythmias.

作者信息

Schamroth L, Krikler D M, Garrett C

出版信息

Br Med J. 1972 Mar 11;1(5801):660-2. doi: 10.1136/bmj.1.5801.660.

Abstract

Verapamil was administered by intravenous injection to 181 patients with various cardiac arrhythmias. The automaticity of the cardiac pacemaker was slowed in sinus, idionodal, and idioventricular tachycardia. In atrial fibrillation the drug usually slowed the ventricular response and often made it regular. In some cases atrial flutter was converted to sinus rhythm, the ventricular response being reduced in the remainder. Conversion of paroxysmal supraventricular tachycardia to sinus rhythm was consistently achieved. A favourable response occurred in four patients in whom arrhythmias were associated with pre-excitation syndromes. There were no adverse clinical side effects.

摘要

对181例各种心律失常患者进行了维拉帕米静脉注射。在窦性、结性和室性心动过速中,心脏起搏器的自律性减慢。在心房颤动中,该药通常会减慢心室反应并常常使其规律化。在某些情况下,心房扑动可转变为窦性心律,其余患者的心室反应则降低。阵发性室上性心动过速持续转变为窦性心律。4例心律失常与预激综合征相关的患者出现了良好反应。未出现不良临床副作用。

相似文献

1
Immediate effects of intravenous verapamil in cardiac arrhythmias.
Br Med J. 1972 Mar 11;1(5801):660-2. doi: 10.1136/bmj.1.5801.660.
2
Effects of intravenous verapamil on cardiac arrhythmias and on the electrocardiogram.
Am Heart J. 1975 Oct;90(4):487-98. doi: 10.1016/0002-8703(75)90431-7.
3
The effect of magnesium versus verapamil on supraventricular arrhythmias.
Clin Cardiol. 1993 May;16(5):429-34. doi: 10.1002/clc.4960160512.
6
Clinical experience with verapamil.
Med J Aust. 1975 Sep 13;2(11):417-21.
8
Verapamil in cardiac arrhythmias: an overview.
Clin Exp Pharmacol Physiol Suppl. 1982;6:129-34.
10
Verapamil in atrial fibrillation and atrial flutter.
Clin Pharmacol Ther. 1979 Nov;26(5):578-83. doi: 10.1002/cpt1979265578.

引用本文的文献

1
In The Line of Treatment: A Systematic Review of Paroxysmal Supraventricular Tachycardia.
Cureus. 2021 Jun 7;13(6):e15502. doi: 10.7759/cureus.15502. eCollection 2021 Jun.
2
Verapamil and Alzheimer's Disease: Past, Present, and Future.
Front Pharmacol. 2020 May 5;11:562. doi: 10.3389/fphar.2020.00562. eCollection 2020.
3
Early afterdepolarisation tendency as a simulated pro-arrhythmic risk indicator.
Toxicol Res (Camb). 2017 Nov 1;6(6):912-921. doi: 10.1039/c7tx00141j. Epub 2017 Sep 14.
4
A comparison of verapamil and digoxin for heart rate control in atrial fibrillation.
Adv Pharm Bull. 2012;2(2):201-5. doi: 10.5681/apb.2012.031. Epub 2012 Aug 15.
5
Selecting a calcium channel-blocking agent.
Can Fam Physician. 1987 Apr;33:1019-23.
6
Cardiac mitochondria and arrhythmias.
Cardiovasc Res. 2010 Nov 1;88(2):241-9. doi: 10.1093/cvr/cvq231. Epub 2010 Jul 9.
7
Calcium antagonists: A new class of therapeutic agents.
Cardiovasc Dis. 1981 Sep;8(3):413-420.
8
Dennis Michael Krikler.
Clin Cardiol. 2002 Feb;25(2):86-7. doi: 10.1002/clc.4950250211.
9

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验